Skip to main content
. 2014 Jan 26;24(1):75–80.

Table 1.

Clinical characteristics of the 54 patients at presentation

Variable Characteristic No Patients (%)
Sex Female 19 (35.2)
Male 35 (64.8)
Immunophenotyping T-lineage 40 (74.1)
B-lineage 14 (25.9)
Stage category stage 30 (55.6)
stage 24 (44.4)
Chemotherapy NHL-BFM-95 protocol 23 (42.6)
modified NHL-BFM-95 protocol 31 (57.4)

NHL-BFM-95 protocol: Non-Hodgkin Lymphoma– Berlin-Frankfurt-Munster-95 protocol